Evidence for Internalization of the Recognition Site of Beta-adrenergic Receptors During Receptor Subsensitivity Induced by (-)-isoproterenol
Overview
Authors
Affiliations
In the supernatant (30,000 x g) of frog erythrocyte homogenates, by using gel filtration we detected a protein that could bind [(3)H]dihydroalprenolol ([(3)H]DHA) with high affinity. This binding was greatly enhanced when the erythrocytes were preincubated with (-)-isoproterenol. After various periods of incubation with (-)-isoproterenol, the extent of the increase in the density of [(3)H]DHA binding sites in the cytosol was paralleled by a proportional decrease in the number of [(3)H]DHA binding sites in the corresponding pellet; both events peaked after 2-3 hr of incubation with (-)-isoproterenol. The K(a) of the (-)-isoproterenol-induced increase in [(3)H]DHA binding in cytosol and the decrease in this binding in the membrane ranged between 60 and 90 nM. The changes in the cytosol and particulate [(3)H]DHA binding sites were independent of RNA and protein synthesis. The increase in cytosol binding elicited by (-)-isoproterenol was blocked by exposure of the cells to (-)-alprenolol which per se failed to change the cytosol binding of [(3)H]DHA. Scatchard analysis revealed that the enhanced [(3)H]DHA binding to cytosol material was due to a 4-fold increase in the B(max) with little or no change in K(d) ( approximately 9 nM). Binding displacement data show that these soluble [(3)H]DHA binding sites resemble the surface membrane recognition sites. Moreover, the ability of various beta-adrenergic agents to increase [(3)H]DHA binding to cytosol after they were incubated with frog erythrocytes paralleled their affinity for membrane-bound beta receptors. These findings support the view that the beta-adrenergic receptor desensitization caused by prolonged exposure to (-)-isoproterenol is due, at least in part, to an internalization of the recognition site of beta-adrenergic receptors.
Cholesterol-dependent endocytosis of GPCRs: implications in pathophysiology and therapeutics.
Kumar G, Chattopadhyay A Biophys Rev. 2022; 13(6):1007-1017.
PMID: 35059024 PMC: 8724494. DOI: 10.1007/s12551-021-00878-7.
Lobingier B, Von Zastrow M Traffic. 2018; 20(2):130-136.
PMID: 30578610 PMC: 6387827. DOI: 10.1111/tra.12634.
Ferreira-Santos L, Martinez D, Nicolau J, Moreira H, Alves M, Pereira A PLoS One. 2017; 12(2):e0173061.
PMID: 28235084 PMC: 5325615. DOI: 10.1371/journal.pone.0173061.
Prolyl hydroxylase 2: a novel regulator of β2 -adrenoceptor internalization.
Yan B, Huo Z, Liu Y, Lin X, Li J, Peng L J Cell Mol Med. 2011; 15(12):2712-22.
PMID: 21255264 PMC: 4373440. DOI: 10.1111/j.1582-4934.2011.01268.x.
Immunoanalogue of vertebrate beta-adrenergic receptor in the unicellular eukaryote Paramecium.
Wiejak J, Surmacz L, Wyroba E Histochem J. 2002; 34(1-2):51-6.
PMID: 12365800 DOI: 10.1023/a:1021399926461.